Below are Quote on CRISIL Ltd -2QCY21 - Result Update by Mr. Amarjeet Maurya, AVP - Mid Caps, Angel Broking Ltd
CRISIL Ltd (CRISIL) 2QCY21 results in-line with expectation. The consolidated top-line grew by ~12% yoy to Rs529cr on the back of healthy growth in Research services ( revenue grew by ~20% yoy) and Advisory services (revenue grew by ~14% yoy). However, Rating services revenue de-grew by ~5% yoy.
On the consolidated EBITDA front, the company has reported ~Rs139cr, grew by 20% on account of lower cost. CRISIL reported EBITDA margin improvement (up by 172bp YoY to 26.4%). The reported consolidated net profit grew by ~52% YoY to Rs101cr, on account of healthy top-line growth and better operating performance. Considering well-diversified business mix, and relentless focus on analytical excellence, hence we are positive on the stock.
CRISIL declared an interim dividend of Rs 8 per share (of Re 1 face value) in the current quarter for the financial year ended December 31, 2021, compared with Rs 6 per share interim dividend declared during the quarter ended June 30, 2020.
Above views are of the author and not of the website kindly read disclaimer